Press release
Rosacea Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline Therapies, Mechanism of Action, Route of Administration, companies by DelveInsight | AOBiome, Maruho, AOBiome, CAGE Bio, BioMimetix JV, Amgen, Alfasigma, AiViva BioPharma, BioPha
Rosacea Clinical Trials
"Rosacea Pipeline Insight, 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Rosacea Therapeutics Market.
The report provides a detailed description of the Rosacea drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Rosacea Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/rosacea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key takeaways from the Rosacea Pipeline Report:
• Rosacea Companies across the globe are diligently working toward developing novel Rosacea treatment therapies with a considerable amount of success over the years.
• Rosacea companies working in the treatment market are Sol-Gel Technologies, Maruho Co., Ltd., AOBiome LLC, CAGE Bio Inc., Dermata Therapeutics, BioMimetix JV, LLC, Dr. Reddy's Laboratories, Amgen, Alfasigma, AiViva BioPharma, BioPharmX, Inc., Botanix Pharmaceuticals, Evommune, Tarus Pharmaceuticals, Cellix Bio, Fortress Biotech, AOBiome, and others are developing therapies for the Rosacea treatment
• Emerging Rosacea therapies such as Epsolay, M 1220, BMX-010, and others are expected to have a significant impact on the Rosacea market in the coming years.
• June 2023: Sol-Gel Technologies, Ltd. and Searchlight Pharma Inc. signed an exclusive license agreement for TWYNEO and EPSOLAY for the Canadian market. EPSOLAY (benzoyl peroxide, 5% cream) treats inflammatory lesions of rosacea in adults.
• April 2023: Zydus Lifesciences received final approval from the drug regulator, the United States FDA, to manufacture and market Metronidazole Topical cream to treat rosacea in the United States market.
Rosacea Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Rosacea therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Rosacea treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Rosacea drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Rosacea treatment market.
Learn More about the Clinical and Commercial Development Activities in the Rosacea Therapeutics Domain @
https://www.delveinsight.com/report-store/rosacea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Rosacea Therapeutics Analysis
There are approx. 25+ key companies developing therapies for Rosacea. Currently, Sol-Gel Technologies is leading the therapeutics market with its Rosacea drug candidates in the most advanced stage of clinical development.
Rosacea Companies in the Therapeutics Market Include:
• Sol-Gel Technologies
• Maruho Co., Ltd.
• AOBiome LLC
• CAGE Bio Inc.
• Dermata Therapeutics
• BioMimetix JV, LLC
• Dr Reddys Laboratories
• Amgen
• Alfasigma
• AiViva BioPharma
• BioPharmX, Inc.
• Botanix Pharmaceuticals
• Evommune
• Tarus Pharmaceuticals
• Cellix Bio.
• Fortress Biotech
• AOBiome
And Many Others
Emerging and Marketed Rosacea Therapies Covered in the Report Include:
• Epsolay: Sol-Gel Technologies
• M 1220: Maruho Ltd.,
• BMX-010: BioMimetix
And Many More
Get an in-depth Assessment of the Emerging Therapies and Rosacea Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/rosacea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Report Covers the Emerging Rosacea Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Rosacea pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Rosacea Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/rosacea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Report Introduction
2. Executive Summary
3. Rosacea Current Treatment Patterns
4. Rosacea - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Rosacea Late-Stage Products (Phase-III)
7. Rosacea Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Rosacea Discontinued Products
13. Rosacea Product Profiles
14. Rosacea Companies
15. Rosacea Drugs
16. Dormant and Discontinued Products
17. Rosacea Unmet Needs
18. Rosacea Future Perspectives
19. Rosacea Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/rosacea-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Pemphigus Vulgaris Market: https://www.delveinsight.com/infographics/pemphigus-vulgaris-market
• Prader-willi Syndrome Market: https://www.delveinsight.com/report-store/prader-willi-syndrome-market
• Radiation Toxicity Market: https://www.delveinsight.com/report-store/radiation-toxicity-market
• Rituximab Biosimilars Insight: https://www.delveinsight.com/report-store/rituximab-biosimilars-insight
• Sjogren's Syndrome Market: https://www.delveinsight.com/report-store/sjogrens-syndrome-market-size
• Spasticity Market: https://www.delveinsight.com/report-store/muscle-spasticity-market
• T-cell-prolymphocytic Leukemia Market: https://www.delveinsight.com/report-store/t-cell-prolymphocytic-leukemia-market
• Thymic Carcinoma Market: https://www.delveinsight.com/report-store/thymus-cancer-market
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/trigeminal-neuralgia-market
• Uncomplicated Urinary Tract Infections Market: https://www.delveinsight.com/report-store/uncomplicated-urinary-tract-infection-uuti-market
• Urolithiasis Market: https://www.delveinsight.com/report-store/urolithiasis-management-devices-market
• Ventricular Dysfunction Market: https://www.delveinsight.com/report-store/ventricular-dysfunction-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/competitive-benchmarking-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rosacea Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline Therapies, Mechanism of Action, Route of Administration, companies by DelveInsight | AOBiome, Maruho, AOBiome, CAGE Bio, BioMimetix JV, Amgen, Alfasigma, AiViva BioPharma, BioPha here
News-ID: 3720481 • Views: …
More Releases from DelveInsight Business Research
Chronic Pulmonary Infections Treatment Market 2032: Clinical Trials, EMA, PDMA, …
(Albany, USA) DelveInsight's "Chronic Pulmonary Infections Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Pulmonary Infections, historical and forecasted epidemiology as well as the Chronic Pulmonary Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Chronic Pulmonary Infections market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and…
Clostridium Difficile Infections Pipeline and Clinical Trials 2025: EMA, PDMA, F …
(Albany, United States) As per DelveInsight's assessment, globally, Clostridium Difficile Infections pipeline constitutes 20+ key companies continuously working towards developing 22+ Clostridium Difficile Infections treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Clostridium Difficile Infections Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Clostridium Difficile Infections Market.
The Clostridium Difficile Infections…
Complicated Urinary Tract Infection Pipeline and Clinical Trials 2025: EMA, PDMA …
(Albany, United States) "Complicated Urinary Tract Infection (UTI) Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Complicated Urinary Tract Infection Therapeutics Market.
As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Complicated Urinary Tract Infection therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action…
Genital Warts Clinical Trials Assessment 2025: PDMA, EMA, FDA Approvals, Medicat …
(New York, United States) "Genital Warts Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Genital Warts Market.
As per DelveInsight's assessment, globally, Genital Warts pipeline constitutes 30+ key companies continuously working towards developing 30+ Genital Warts treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Genital Warts Pipeline report embraces in-depth…
More Releases for Rosacea
The Rosacea Treatment Market to sail through predictive analysis
The Rosacea Treatment Market is expected to grow on a healthy note further. The current scenario is such that virtual monitoring tools are being called for. They act as a precision factor for the healthcare vertical. With the turning out to be more accessible for patients and providers alike, several post-operative intervention options are being made available for preventing hospital re-admittance and complications. With cost-effectiveness rendered as well, the healthcare…
Acne & Rosacea Market Analysis Forecast Report 2022 – MarketReportsOnline
MarketReportsOnline.com adds "US Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)" report to its research store.
The report “U.S. Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)” provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. market. The report profiles the key players of the market including Bausch…
Rosacea Treatment Market Report 2018: Segmentation by Product (Topical therapy, …
Global Rosacea Treatment market research report provides company profile for Allergan, Dermik Laboratories Inc, Merz Pharma GmbH & Co. KGaA, Galderma, Valeant Pharmaceuticals, Bayer, Mayne Pharma and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Rosacea Therapeutics Market Overview and forecasts to 2024
Rosacea Therapeutics Market: Overview
The American Academy of Dermatology states that over 14 million people are currently living with rosacea in the U.S. alone. The Canadian Dermatology Association reports that this chronic skin condition affects over two million people in the country, while the British Skin Foundation finds that more than eight million people in the U.K. suffer from various skin conditions, including rosacea. The rising incidence of this skin disease…
Rosacea Therapeutics Market Trends and Prospects by 2024
Rosacea Therapeutics Market: Overview
The American Academy of Dermatology states that over 14 million people are currently living with rosacea in the U.S. alone. The Canadian Dermatology Association reports that this chronic skin condition affects over two million people in the country, while the British Skin Foundation finds that more than eight million people in the U.K. suffer from various skin conditions, including rosacea. The rising incidence of this skin disease…
Rosacea Therapeutics Market Analysis, Growth & Forecast 2024
Rosacea Therapeutics Market: Overview
The American Academy of Dermatology states that over 14 million people are currently living with rosacea in the U.S. alone. The Canadian Dermatology Association reports that this chronic skin condition affects over two million people in the country, while the British Skin Foundation finds that more than eight million people in the U.K. suffer from various skin conditions, including rosacea. The rising incidence of this skin…
